| Legal, Health, Environmental and COVID-19 Challenges | Lifetime | 4 | PH 1 | 99.21 |
| Vaccine Coverage and Hesitancy | Lifetime | 433 | PH 1 | 97.12 |
| COVID-19 epidemiological studies | Lifetime | 483 | PH 1 | 96.72 |
| Viral Infections and Outbreaks Research | Lifetime | 478 | PH 1 | 95.93 |
| Zoonotic diseases and public health | Lifetime | 400 | PH 1 | 94.98 |
| COVID-19 Pandemic Impacts | Lifetime | 396 | PH 2 | 92.44 |
| Diverse Scientific Research in Ukraine | Lifetime | 212 | PH 1 | 93.08 |
| Healthcare Systems and Reforms | Lifetime | 536 | PH 2 | 94.53 |
| Environmental and Biological Research in Conflict Zones | Lifetime | 129 | PH 1 | 93.02 |
| Immune responses and vaccinations | Lifetime | 435 | PH 1 | 89.22 |
| Global Health and Surgery | Lifetime | 916 | PH 3 | 82.48 |
| Health and Conflict Studies | Lifetime | 944 | PH 1 | 75.06 |
| Pharmaceutical Quality and Counterfeiting | Lifetime | 544 | PH 1 | 59.95 |
| Economic Sanctions and International Relations | Lifetime | 705 | PH 2 | 61.59 |
| Global Security and Public Health | Lifetime | 793 | PH 1 | 53.80 |
| Viral Infections and Outbreaks Research | 2021-2025 | 3 | PH 1 | 99.15 |
| COVID-19 epidemiological studies | 2021-2025 | 42 | PH 1 | 98.89 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 41 | PH 1 | 98.91 |
| Global Maternal and Child Health | 2021-2025 | 46 | PH 1 | 99.06 |
| Zoonotic diseases and public health | 2021-2025 | 12 | PH 1 | 98.61 |
| Healthcare Systems and Reforms | 2021-2025 | 47 | PH 1 | 96.87 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 605 | PH 1 | 97.59 |
| Immune responses and vaccinations | 2021-2025 | 26 | PH 1 | 95.99 |
| Legal, Health, Environmental and COVID-19 Challenges | 2021-2025 | 9 | PH 1 | 94.86 |
| COVID-19 Pandemic Impacts | 2021-2025 | 238 | PH 2 | 92.86 |
| Global Public Health Policies and Epidemiology | 2021-2025 | 194 | PH 1 | 90.91 |
| Global Cancer Incidence and Screening | 2021-2025 | 454 | PH 1 | 92.94 |
| Virology and Viral Diseases | 2021-2025 | 157 | PH 2 | 87.96 |
| Global Health and Surgery | 2021-2025 | 142 | PH 2 | 87.49 |
| Environmental and Biological Research in Conflict Zones | 2021-2025 | 47 | PH 1 | 88.05 |
| Global Health Care Issues | 2021-2025 | 571 | PH 2 | 83.16 |
| Diverse Scientific Research in Ukraine | 2021-2025 | 204 | PH 1 | 84.32 |
| Antibiotic Use and Resistance | 2021-2025 | 943 | PH 1 | 85.39 |
| HIV/AIDS Impact and Responses | 2021-2025 | 151 | PH 1 | 79.69 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 403 | PH 1 | 79.56 |
| Health and Conflict Studies | 2021-2025 | 104 | PH 1 | 80.78 |
| Cancer Risks and Factors | 2021-2025 | 591 | PH 1 | 81.14 |
| Bacillus and Francisella bacterial research | 2021-2025 | 400 | PH 2 | 77.71 |
| Disaster Response and Management | 2021-2025 | 610 | PH 5 | 79.50 |
| Poxvirus research and outbreaks | 2021-2025 | 392 | PH 2 | 79.61 |
| Pharmaceutical Economics and Policy | 2021-2025 | 511 | PH 1 | 80.16 |
| Public Health Policies and Education | 2021-2025 | 169 | PH 1 | 77.22 |
| Pharmaceutical Quality and Counterfeiting | 2021-2025 | 74 | PH 1 | 72.68 |
| Blood donation and transfusion practices | 2021-2025 | 524 | PH 1 | 67.36 |
| Global Security and Public Health | 2021-2025 | 103 | PH 1 | 61.57 |
| Menstrual Health and Disorders | 2021-2025 | 573 | PH 2 | 57.24 |
| Travel-related health issues | 2021-2025 | 432 | PH 2 | 54.47 |
| History of Medical Practice | 2021-2025 | 182 | PH 2 | 47.83 |
| Global Healthcare and Medical Tourism | 2021-2025 | 316 | PH 2 | 43.56 |
